SPY423.47-0.84 -0.20%
DIA342.87-2.25 -0.65%
IXIC14,134.85+65.43 0.47%

BTIG Maintains Buy on Guardant Health, Raises Price Target to $160

BTIG maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $145 to $160.

05/07/2021 10:00
BTIG maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $145 to $160.